NTIMCH
NAGE

New Thinking Investment Management Company (HK)’s Niagen Bioscience NAGE Stock Holding History

New Thinking Investment Management Company (HK)’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-137,614
Closed -$1.36M – 6
2021
Q2 		$1.36M Buy
+137,614
New +$1.2M 1.15% 4

Other funds holding NAGE

YRHAM
Yong Rong (HK) Asset Management Sheung Wan, Hong Kong $119M AUM 233.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $1.07B AUM 34.04% 1-Year Est. Return

New Thinking Investment Management Company (HK)'s NAGE Position: Q3 2021 in Review

New Thinking Investment Management Company (HK) sold out of Niagen Bioscience (NAGE) in Q3 2021, closing a stake of 137,614 shares — an estimated $1.36M sold.

New Thinking Investment Management Company (HK) first reported a position in NAGE in Q2 2021 and held it in 1 quarter. The position peaked at $1.36M in Q2 2021. 86 funds tracked by Wall St. Rank hold NAGE as of Q3 2021.

  • New Thinking Investment Management Company (HK) reported no remaining Niagen Bioscience position as of Q3 2021 after selling out during the quarter.
  • New Thinking Investment Management Company (HK) sold 137,614 Niagen Bioscience shares in Q3 2021, an estimated $1.36M.
  • New Thinking Investment Management Company (HK) first reported a position in Niagen Bioscience in Q2 2021 and held it in 1 quarter.
  • New Thinking Investment Management Company (HK)'s Niagen Bioscience position peaked at $1.36M in Q2 2021.
  • 86 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2021.

Based on New Thinking Investment Management Company (HK)'s 13F filing for Q3 2021, filed 29 Oct 2021.